These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 37067443)

  • 21. Evolutionary Rationale for Phages as Complements of Antibiotics.
    Torres-Barceló C; Hochberg ME
    Trends Microbiol; 2016 Apr; 24(4):249-256. PubMed ID: 26786863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phage therapy as strategy to face post-antibiotic era: a guide to beginners and experts.
    Royer S; Morais AP; da Fonseca Batistão DW
    Arch Microbiol; 2021 May; 203(4):1271-1279. PubMed ID: 33474609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controlled phage therapy by photothermal ablation of specific bacterial species using gold nanorods targeted by chimeric phages.
    Peng H; Borg RE; Dow LP; Pruitt BL; Chen IA
    Proc Natl Acad Sci U S A; 2020 Jan; 117(4):1951-1961. PubMed ID: 31932441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Propagation, Purification, and Characterization of Bacteriophages for Phage Therapy.
    Kosznik-Kwaśnicka K; Topka G; Mantej J; Grabowski Ł; Necel A; Węgrzyn G; Węgrzyn A
    Methods Mol Biol; 2024; 2738():357-400. PubMed ID: 37966610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phage therapy for respiratory infections.
    Chang RYK; Wallin M; Lin Y; Leung SSY; Wang H; Morales S; Chan HK
    Adv Drug Deliv Rev; 2018 Aug; 133():76-86. PubMed ID: 30096336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacteriophages and antibiotic interactions in clinical practice: what we have learned so far.
    Łusiak-Szelachowska M; Międzybrodzki R; Drulis-Kawa Z; Cater K; Knežević P; Winogradow C; Amaro K; Jończyk-Matysiak E; Weber-Dąbrowska B; Rękas J; Górski A
    J Biomed Sci; 2022 Mar; 29(1):23. PubMed ID: 35354477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative analysis of effectiveness for phage cocktail development against multiple Salmonella serovars and its biofilm control activity.
    Ribeiro JM; Pereira GN; Durli Junior I; Teixeira GM; Bertozzi MM; Verri WA; Kobayashi RKT; Nakazato G
    Sci Rep; 2023 Aug; 13(1):13054. PubMed ID: 37567926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bacteriophages of the Urinary Microbiome.
    Miller-Ensminger T; Garretto A; Brenner J; Thomas-White K; Zambom A; Wolfe AJ; Putonti C
    J Bacteriol; 2018 Apr; 200(7):. PubMed ID: 29378882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phage therapy--constraints and possibilities.
    Nilsson AS
    Ups J Med Sci; 2014 May; 119(2):192-8. PubMed ID: 24678769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacteriophage cocktail and phage antibiotic synergism as promising alternatives to conventional antibiotics for the control of multi-drug-resistant uropathogenic Escherichia coli.
    Malik S; Nehra K; Rana JS
    Virus Res; 2021 Sep; 302():198496. PubMed ID: 34182014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacteriophages: The promising therapeutic approach for enhancing ciprofloxacin efficacy against bacterial infection.
    Shariati A; Noei M; Chegini Z
    J Clin Lab Anal; 2023 May; 37(9-10):e24932. PubMed ID: 37377167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Phage therapy, an additional strategy against multidrug-resistant bacteria].
    Boniver M; Wotquenne P; Moutschen M; Rousseau AF
    Rev Med Liege; 2022 Sep; 77(9):510-515. PubMed ID: 36082597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phage-Antibiotic Synergy Is Driven by a Unique Combination of Antibacterial Mechanism of Action and Stoichiometry.
    Gu Liu C; Green SI; Min L; Clark JR; Salazar KC; Terwilliger AL; Kaplan HB; Trautner BW; Ramig RF; Maresso AW
    mBio; 2020 Aug; 11(4):. PubMed ID: 32753497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Engineered Bacteriophage Therapeutics: Rationale, Challenges and Future.
    Łobocka M; Dąbrowska K; Górski A
    BioDrugs; 2021 May; 35(3):255-280. PubMed ID: 33881767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacteriophages: an overview of the control strategies against multiple bacterial infections in different fields.
    Jamal M; Bukhari SMAUS; Andleeb S; Ali M; Raza S; Nawaz MA; Hussain T; Rahman SU; Shah SSA
    J Basic Microbiol; 2019 Feb; 59(2):123-133. PubMed ID: 30485461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The therapeutic potential of bacteriophages targeting gram-negative bacteria using Galleria mellonella infection model.
    Manohar P; Nachimuthu R; Lopes BS
    BMC Microbiol; 2018 Aug; 18(1):97. PubMed ID: 30170558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation, characterization, therapeutic potency, and genomic analysis of a novel bacteriophage vB_KshKPC-M against carbapenemase-producing Klebsiella pneumoniae strains (CRKP) isolated from Ventilator-associated pneumoniae (VAP) infection of COVID-19 patients.
    Mohammadi M; Saffari M; Siadat SD; Hejazi SH; Shayestehpour M; Motallebi M; Eidi M
    Ann Clin Microbiol Antimicrob; 2023 Feb; 22(1):18. PubMed ID: 36829156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phage Therapy in Bacterial Infections Treatment: One Hundred Years After the Discovery of Bacteriophages.
    Cisek AA; Dąbrowska I; Gregorczyk KP; Wyżewski Z
    Curr Microbiol; 2017 Feb; 74(2):277-283. PubMed ID: 27896482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation of a Virulent
    Xu Z; Jin P; Zhou X; Zhang Y; Wang Q; Liu X; Shao S; Liu Q
    Appl Environ Microbiol; 2021 Oct; 87(21):e0146821. PubMed ID: 34406829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The disparate effects of bacteriophages on antibiotic-resistant bacteria.
    Torres-Barceló C
    Emerg Microbes Infect; 2018 Oct; 7(1):168. PubMed ID: 30302018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.